Senior Director / Executive Director, HCP Marketing

Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of congenital and acquired forms of hyperinsulinism (HI). Rezolute’s mission is to bring hope and meaningful solutions to patients and families affected by rare diseases through scientific innovation, collaboration, and integrity.

Position Overview:

The Senior Director / Executive Director, HCP Marketing, will support strategy development and lead tactical execution focused on a new product launch in congenital hyperinsulinism (cHI). This role will report to the Vice-President, Commercial Strategy, and requires expertise in personal promotions and thought leader engagement, as well as experience in a rare disease launch. This role will also be responsible for supporting HCP market research in collaboration with the Commercial Data & Analytics team, to drive insights that shape marketing strategy and support the commercial success of Rezolute’s rare disease product. This position will work closely with cross-functional teams, including Medical Affairs, Sales, Market Access, Legal, Regulatory and Compliance.